TY - JOUR T1 - Design of optical cavity for air sanification through ultraviolet germicidal irradiation JF - medRxiv DO - 10.1101/2021.03.04.21252517 SP - 2021.03.04.21252517 AU - Matteo Lombini AU - Emiliano Diolaiti AU - Adriano De Rosa AU - Luigi Lessio AU - Giovanni Pareschi AU - Andrea Bianco AU - Fausto Cortecchia AU - Mauro Fiorini AU - Giulia Fiorini AU - Giuseppe Malaguti AU - Alessio Zanutta Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/08/2021.03.04.21252517.abstract N2 - The transmission of airborne pathogens represents a major issue to worldwide public health. Ultraviolet light irradiation can contribute to the sanification of air to reduce the pathogen transmission. This study concerns the design of a compact filter for airborne pathogen inactivation by means of UV-C LED sources, whose effective irradiance is enhanced thanks to high reflective surfaces. Ray-tracing and computational fluid dynamic simulations are both used to model the device and to maximize the performance inside the filter volume. Simulations foresee the inhibition of SARS-Cov 2 also in the case of high air fluxes. This study demonstrates that current available LED technology is effective for air sanification purposes.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:no ethics committee was necessary for this paperAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesno data have been used ER -